Nanotein engages Akron Bio for the cGMP production of its NanoSpark® STEM-T Soluble T Cell Activator

BERKELEY, CA – Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® platform, and Akron Bio (“Akron”), a leading supplier of critical materials and services for advanced therapies, today announced a partnership for the cGMP production of Nanotein’s NanoSpark® STEM-T Soluble T cell activator.

Read the full press release on Business Wire.